Limited role of direct exchange arthroplasty in the treatment of infected total hip replacements

Clinical Orthopaedics and Related Research

Volumn 381, Issue , 2000, Pages 101-105

  Jackson, Walter O ^a   Schmalzried, Thomas P ^b  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b JOINT REPLACEMENT INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BONE CEMENT;

ANTIBIOTIC THERAPY; CONFERENCE PAPER; COXITIS; DIRECT EXCHANGE ARTHROPLASTY; HEALTH STATUS; HUMAN; PRIORITY JOURNAL; PSEUDOMONAS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS; STREPTOCOCCUS GROUP D; TOTAL HIP PROSTHESIS;

EID: 0033660155     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/00003086-200012000-00012     Document Type: Conference Paper

References (32)

1. Outcome of the infected hip arthroplasty a retrospective study of 36 patients
2. Management of deep infection of total hip replacement
3. The management of deep infection involving joint implants
4. Revision with gentamicin-impregnated cement for deep infections in total hip arthroplasties
5. Prophylactic antibiotics against early and late deep infections after total hip replacements
6. Total hip replacement in the previously septic hip
7. Treatment of infection with debridement and retention of the components following hip arthroplasty
8. One-stage exchange in the treatment of the infected total hip arthroplasty
9. Reconstruction of the infected total hip and knee arthroplasty with gentamicin-impregnated Palacos bone cement
10. Infection after total hip arthroplasty
11. Deep infection of cemented total hip arthroplasties caused by coagulase-negative staphylococci
12. Treatment of subacute sepsis of the hip by antibiotics and joint replacement criteria for diagnosis with evaluation of twenty-six cases
13. Methicillin-resistant staphylococcus aureus (MRSA)-A reappraisal of control measures in the light of changing circumstances
14. The results of reinsertion of a total hip prosthesis after sepsis
15. A minimum ten year follow-up study of one stage reimplantation of the infected total hip
16. Analysis of three operative techniques for infected total hip replacements
17. 5- to 13-Year follow-up study on cementless femoral components in revision surgery
18. Revision of the acetabulum without cement with use of the Harris-Galante porous-coated implant
19. The experience with antibiotic cement in Sweden
20. Acetabular revision options
21. Medical and surgical treatment of the septic hip with one-stage revision arthroplasty
22. Use of antibiotic-containing bone cement
23. Direct exchange arthroplasty in 30 septic total hip replacements without recurrent infection
24. Intrinsically vancomycin-resistant gram-positive organisms: Clinical relevance and implications for infection control
25. Revision of the acetabular component without cement after total hip arthroplasty
26. Five to 14-year follow up on cementless femoral revisions
27. One-stage revision of infected total hip replacements with discharging sinuses
28. Revision operations on infected total hip arthroplasties two- to nine-year follow-up study
29. Deep-wound infection after total hip replacement under contemporary aseptic conditions
30. Revision of the acetabular component with an uncemented Harris-Galante porous-coated prosthesis
31. Direct-exchange arthroplasty for the treatment of infection after total hip replacement
32. One-stage revision of infected cemented total hip arthroplasty